Expression of epidermal growth factor receptor in breast carcinoma

scientific article published on May 1990

Expression of epidermal growth factor receptor in breast carcinoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/JCP.43.5.385
P932PMC publication ID502437
P698PubMed publication ID2370306
P5875ResearchGate publication ID20786397

P50authorIan EllisQ55300055
P2093author name stringLewis S
Elston CW
Blamey RW
Bell JA
Nicholson R
Todd JH
Locker A
P2860cites workHuman epidermal growth factor: isolation and chemical and biological propertiesQ35075356
Breast cancer and a proto-oncogeneQ35718067
Confirmation of a prognostic index in primary breast cancer.Q36028322
Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancerQ37195907
Evidence for the involvement of the submandibular gland epidermal growth factor in mouse mammary tumorigenesisQ37531550
Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinomaQ39761350
Growth requirements of human mammary epithelial cells in cultureQ40664330
Estrogen receptor assay in primary breast cancer and early recurrence of the diseaseQ43975464
Prognostic factors in breast cancer -- the formation of a prognostic indexQ66958131
Epidermal-growth-factor receptors and oestrogen receptors in human breast cancerQ69856765
Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancerQ69900051
Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancerQ70046632
Epidermal growth factor stimulation of human breast cancer cells in cultureQ72076778
Cellular localisation of human epidermal growth factor receptorQ72392851
Receptor Binding and Processing of Epidermal Growth Factor by Human Breast Cancer Cells*Q72929970
Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animalQ79368389
P433issue5
P407language of work or nameEnglishQ1860
P304page(s)385-389
P577publication date1990-05-01
P1433published inJournal of Clinical PathologyQ6294965
P1476titleExpression of epidermal growth factor receptor in breast carcinoma
P478volume43

Reverse relations

cites work (P2860)
Q71635509A dual immunocytochemical assay for oestrogen and epidermal growth factor receptors in tumour cell lines
Q41053705A multiparametric study on the prognostic value of epidermal growth factor receptor in operable breast carcinoma
Q72088667An immunocytochemical analysis of TGFα expression in benign and malignant prostatic tumors
Q62690657Analysis of the genes for oestrogen and epidermal growth factor receptors in human breast cancer
Q40848953Biological indices in the assessment of breast cancer
Q35017851Chromatin structure of the EGFR gene suggests a role for intron 1 sequences in its regulation in breast cancer cells
Q36194648Clinicopathological Characteristics and Survival Outcomes of Invasive Cribriform Carcinoma of Breast: A SEER Population-Based Study
Q59487603Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survival
Q36537922Detection of tumor antigens with monoclonal antibodies: immunopathology and immunodiagnosis
Q46654519Determination of epidermal growth factor receptor provides additional prognostic information to measuring tumor angiogenesis in breast carcinoma patients
Q36536905Diagnostic utility of oncogenes and their products in human cancer
Q35979084Dual immunocytochemical analysis of oestrogen and epidermal growth factor receptors in human breast cancer
Q71702871Effect of a cytotoxic analog of LH-RH (T-98) on the growth of estrogen-dependent MXT mouse mammary cancers: correlations between growth characteristics and EGF receptor content of tumors
Q70779513Epidermal growth factor receptor and prognosis in human breast cancer: a prospective study
Q44438798Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy.
Q68132983Epidermal growth factor receptors in human breast cancer: a plea for standardisation of assay methodology
Q37970020ErbB family receptor inhibitors as therapeutic agents in breast cancer: current status and future clinical perspective
Q44588191Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor).
Q36696088Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma
Q36115645Expression of c-erbB3 protein in primary breast carcinomas
Q35984818Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder
Q36787372Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas
Q43912153Fatty acid synthase affects expression of ErbB receptors in epithelial to mesenchymal transition of breast cancer cells and invasive ductal carcinoma
Q35228457Hormone receptors in malignancy
Q67491834Immunocytochemistry and in situ hybridisation of epidermal growth factor receptor and relation to prognostic factors in breast cancer
Q35993833Immunohistochemical and other features of breast carcinomas presenting clinically compared with those detected by cancer screening
Q36081088Immunohistochemical assay for epidermal growth factor receptor on paraffin-embedded sections: validation against ligand-binding assay and clinical relevance in breast cancer
Q35993847Influence of the antioestrogen tamoxifen on normal breast tissue
Q62690642Investigation of the mechanisms determining the inverse relationship between oestrogen and epidermal growth factor receptors in primary human breast cancer
Q34987420Molecular alterations in sporadic breast cancer
Q72859996Prevalence of aneuploidy, overexpressed ER, and overexpressed EGFR in random breast aspirates of women at high and low risk for breast cancer
Q41648567Prognostic and response markers in the management of breast cancer
Q40657286Prognostic factors in early breast carcinoma.
Q44845527Proliferating cell nuclear antigen in breast lesions: correlation of c-erbB-2 oncoprotein and EGF receptor and its clinicopathological significance in breast cancer
Q41679383Protein tyrosine kinases and cancer
Q35233707Radish (Raphanus sativus L. leaf) ethanol extract inhibits protein and mRNA expression of ErbB(2) and ErbB(3) in MDA-MB-231 human breast cancer cells
Q54419333Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivity.
Q35992905Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer
Q35993921Response to mitoxantrone in advanced breast cancer: correlation with expression of c-erbB-2 protein and glutathione S-transferases
Q45234395Significance of epidermal growth factor receptor expression in breast cancer
Q35983341The combinatorial approach of laser-captured microdissection and reverse transcription quantitative polymerase chain reaction accurately determines HER2 status in breast cancer
Q40665439The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients
Q33959323The epidermal growth factor receptor in breast cancer.
Q78677643The invasive phenotype in HMT-3522 cells requires increased EGF receptor signaling through both PI 3-kinase and ERK 1,2 pathways
Q43788104The prognostic significance of epidermal growth factor receptor expression in breast cancer
Q35976972The prognostic significance of transforming growth factors in human breast cancer
Q33538455The relationship between prognostic and predictive factors in the management of breast cancer
Q35994620Value of epidermal growth factor receptor status compared with growth fraction and other factors for prognosis in early breast cancer
Q36621288c-erbB-4 protein expression in human breast cancer

Search more.